Thanks to all above responding to the question; I agree that it indicates that the drug is not an approved Orphan drug in terms of marketing, but that the Orphan drug designation is granted. As an aside I wonder if there is any dispensation for continuing the release of the drug to those that were on it during the trial? Seems only fair, but fair isn't necessarily a prime concern in these matters, but given the safety profile...well...it seems fair.
Ajostu, if the FDA posted to their site that the designation was granted on 11/02/2015 as indicated, I would have thought that the Neuren team would have been advised on Thursday or Friday last week our time, enough time for a release to market about Orphan status. Which had me wondering about BTD being known and combined into a single release - pure speculation of course. But who knows - people could be in transit, there may be protocols that control communication to certain timelines and response cues.
Very interested to see a release on Monday, would almost have to arrive pre-open you'd think...
Thanks again to all who responded...have a great Sunday.
- Forums
- ASX - By Stock
- NEU
- FDA Grants Orphan Drug Designation
FDA Grants Orphan Drug Designation, page-19
-
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B |
Open | High | Low | Value | Volume |
$19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5901 | $19.97 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.00 | 3262 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2035 | 19.830 |
5 | 3099 | 19.810 |
3 | 2596 | 19.800 |
1 | 866 | 19.790 |
1 | 3096 | 19.780 |
Price($) | Vol. | No. |
---|---|---|
20.000 | 1036 | 3 |
20.020 | 2119 | 3 |
20.050 | 2151 | 2 |
20.060 | 1000 | 2 |
20.070 | 1145 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online